CellSeed Inc. Logo

CellSeed Inc.

Develops and commercializes cell sheet engineering for regenerative medicine.

7776 | T

Overview

Corporate Details

ISIN(s):
JP3423530009
LEI:
Country:
Japan
Address:
江東区青海2−5−10テレコムセンタービル15F

Description

CellSeed Inc. is a regenerative medicine company centered on the research, development, and commercialization of its proprietary "cell sheet engineering" technology. This innovative platform enables the creation and harvesting of intact sheets of cultured cells without enzymatic treatment, preserving the extracellular matrix and cell-to-cell junctions critical for therapeutic efficacy. The company's business is structured around three core activities: the development of its own pipeline of cell sheet-based therapies for tissue regeneration, the sale of specialized temperature-responsive cell cultureware and related equipment, and the provision of contract development and manufacturing (CDMO) services for regenerative medicine products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-20 08:01
有価証券届出書(参照方式)
Japanese 154.6 KB
2025-08-14 08:48
確認書
Japanese 8.0 KB
2025-08-14 08:47
半期報告書-第25期(2025/01/01-2025/12/31)
Japanese 176.2 KB
2025-03-27 06:07
臨時報告書
Japanese 25.6 KB
2025-03-26 08:00
確認書
Japanese 8.1 KB
2025-03-26 08:00
内部統制報告書-第24期(2024/01/01-2024/12/31)
Japanese 21.2 KB
2025-03-26 07:59
有価証券報告書-第24期(2024/01/01-2024/12/31)
Japanese 827.2 KB
2024-08-14 08:15
確認書
Japanese 8.1 KB
2024-08-14 08:14
半期報告書-第24期(2024/01/01-2024/06/30)
Japanese 181.4 KB
2024-05-15 08:19
確認書
Japanese 8.0 KB
2024-05-15 08:19
四半期報告書-第24期第1四半期(2024/01/01-2024/03/31)
Japanese 145.1 KB
2024-03-28 07:11
臨時報告書
Japanese 22.0 KB
2024-03-28 07:08
確認書
Japanese 8.1 KB
2024-03-28 07:07
内部統制報告書-第23期(2023/01/01-2023/12/31)
Japanese 22.2 KB
2024-03-28 07:04
有価証券報告書-第23期(2023/01/01-2023/12/31)
Japanese 875.2 KB

Automate Your Workflow. Get a real-time feed of all CellSeed Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CellSeed Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CellSeed Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.